PL2559439T3 - Preparat farmaceutyczny do leczenia łagodnego rozrostu gruczołu krokowego - Google Patents
Preparat farmaceutyczny do leczenia łagodnego rozrostu gruczołu krokowegoInfo
- Publication number
- PL2559439T3 PL2559439T3 PL12192951T PL12192951T PL2559439T3 PL 2559439 T3 PL2559439 T3 PL 2559439T3 PL 12192951 T PL12192951 T PL 12192951T PL 12192951 T PL12192951 T PL 12192951T PL 2559439 T3 PL2559439 T3 PL 2559439T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical preparation
- benign prostatic
- prostatic hyperplasia
- treating benign
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0196207A AT506095A1 (de) | 2007-12-03 | 2007-12-03 | Verwendung von proteasen |
EP08856631A EP2224948A1 (en) | 2007-12-03 | 2008-12-03 | Pharmaceutical preparation for treating benign prostatic hyperplasia |
EP12192951.7A EP2559439B1 (en) | 2007-12-03 | 2008-12-03 | Pharmaceutical preparation for treating benign prostatic hyperplasia |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2559439T3 true PL2559439T3 (pl) | 2015-04-30 |
Family
ID=40404976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12192951T PL2559439T3 (pl) | 2007-12-03 | 2008-12-03 | Preparat farmaceutyczny do leczenia łagodnego rozrostu gruczołu krokowego |
Country Status (11)
Country | Link |
---|---|
US (1) | US8231870B2 (pl) |
EP (2) | EP2559439B1 (pl) |
JP (1) | JP2011505385A (pl) |
AT (1) | AT506095A1 (pl) |
CA (1) | CA2705986C (pl) |
DK (1) | DK2559439T3 (pl) |
ES (1) | ES2528348T3 (pl) |
MX (1) | MX2010005629A (pl) |
PL (1) | PL2559439T3 (pl) |
RU (1) | RU2485971C2 (pl) |
WO (1) | WO2009070818A1 (pl) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI482629B (zh) * | 2008-07-01 | 2015-05-01 | Tobishi Pharmaceutical Co | 下泌尿道疾病治療劑及下泌尿道症狀改善劑 |
EP2341925B1 (en) * | 2008-09-10 | 2014-11-26 | PT. Dexa Medica | Thrombolytic/ anti thrombosis agent and its production method |
EP2649994B1 (de) * | 2011-01-31 | 2017-08-30 | LUCOLAS-M.D. Ltd. | Kombinationen von aromatase inhibitoren und antioxidanzien |
WO2012155027A1 (en) | 2011-05-12 | 2012-11-15 | Healthpoint, Ltd. | Wound debridement compositions containing seaprose and methods of wound treatment using same |
WO2013170128A1 (en) * | 2012-05-11 | 2013-11-14 | Smith & Nephew, Inc. | Use of seaprose to remove bacterial biofilm |
ITMI20121997A1 (it) * | 2012-11-23 | 2014-05-24 | Velleja Res Srl | Composizioni fibrinolitiche per la prevenzione e il trattamento degli stati flebotrombotici |
US10086053B2 (en) | 2012-12-06 | 2018-10-02 | Giuseppe CARPIGNOLI | Therapeutic vegetable substances |
ITTO20121050A1 (it) * | 2012-12-06 | 2014-06-07 | Giuseppe Carpignoli | Sostanze vegetali ad effetto curativo |
KR101691479B1 (ko) * | 2013-10-23 | 2017-01-02 | 주식회사 젬백스앤카엘 | 전립선 비대증 치료 및 예방용 조성물 |
HUP1400294A2 (hu) | 2014-06-13 | 2015-12-28 | Skillpharm Kft | Clopidogrel új alkalmazása |
EP3193629B1 (en) * | 2014-08-25 | 2023-01-25 | Anatara Lifesciences Limited | Anti-diarrhea formulation which avoids antimicrobial resistance |
CA3031866A1 (en) | 2016-07-27 | 2018-02-01 | Smith & Nephew, Inc. | Use of thermolysin to reduce or eliminate bacterial biofilms from surfaces |
IT201600081379A1 (it) * | 2016-08-03 | 2018-02-03 | Neilos S R L | Composizione farmaceutica per uso nel trattamento delle patologie prostatiche. |
WO2018140707A1 (en) | 2017-01-30 | 2018-08-02 | Smith & Nephew, Inc. | Synergistic combination of thermolysin and an antibacterial agent to reduce eliminate bacterial biofilms from surfaces |
JP7207877B2 (ja) * | 2018-06-27 | 2023-01-18 | 小林製薬株式会社 | ナットウキナーゼを含む食品 |
JP7207878B2 (ja) * | 2018-06-27 | 2023-01-18 | 小林製薬株式会社 | ナットウキナーゼを含む食品 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990008555A1 (en) * | 1989-01-27 | 1990-08-09 | Immunolytics, Inc. | Composition and method for treating benign prostatic hypertrophy |
JPH05229983A (ja) * | 1992-02-21 | 1993-09-07 | Sankyo Co Ltd | レトロジヒドロカルコン化合物 |
DE4305460C2 (de) | 1993-02-23 | 1997-09-04 | Albert Dr Scheller | Pharmazeutische oder kosmetische, Enzyme enthaltende Zubereitung, Verfahren zu deren Herstellung und deren Verwendung |
JP3978250B2 (ja) * | 1996-08-16 | 2007-09-19 | 株式会社フジモト・コーポレーション | テストステロン5α−リダクターゼ阻害剤 |
US20010025059A1 (en) * | 2000-01-10 | 2001-09-27 | Kastke Floyd A. | Composition and method for treating non-bacterial prostatitis |
ZA200002342B (en) | 2000-05-12 | 2001-01-11 | Pharmachoice Healthcare Propri | Nutritional supplement. |
AU2002350623A1 (en) | 2001-10-26 | 2003-05-06 | The Scripps Research Institute | Targeted thrombosis by tissue factor polypeptides |
BR0214242A (pt) * | 2002-09-19 | 2004-09-21 | Cristiano Alberto Ribe Santana | Composição de substância carreadora de produtos |
LV13161B (en) * | 2004-02-16 | 2005-07-20 | Maris Skromanis | Proteolytic pharmaceutical composition |
US20060024385A1 (en) | 2004-07-27 | 2006-02-02 | Pedersen Mark A | Metabolic capacity enhancing compositions and methods for use in a mammal |
US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
RU2306145C1 (ru) * | 2006-03-28 | 2007-09-20 | Олег Викторович Бейдик | Средство для лечения хронического простатита |
-
2007
- 2007-12-03 AT AT0196207A patent/AT506095A1/de not_active Application Discontinuation
-
2008
- 2008-12-03 US US12/745,776 patent/US8231870B2/en active Active
- 2008-12-03 DK DK12192951.7T patent/DK2559439T3/en active
- 2008-12-03 ES ES12192951.7T patent/ES2528348T3/es active Active
- 2008-12-03 EP EP12192951.7A patent/EP2559439B1/en not_active Not-in-force
- 2008-12-03 WO PCT/AT2008/000428 patent/WO2009070818A1/en active Application Filing
- 2008-12-03 JP JP2010536280A patent/JP2011505385A/ja active Pending
- 2008-12-03 MX MX2010005629A patent/MX2010005629A/es active IP Right Grant
- 2008-12-03 EP EP08856631A patent/EP2224948A1/en not_active Withdrawn
- 2008-12-03 CA CA2705986A patent/CA2705986C/en not_active Expired - Fee Related
- 2008-12-03 PL PL12192951T patent/PL2559439T3/pl unknown
- 2008-12-03 RU RU2010127336/15A patent/RU2485971C2/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2485971C2 (ru) | 2013-06-27 |
EP2559439A1 (en) | 2013-02-20 |
CA2705986C (en) | 2017-06-13 |
US20100254968A1 (en) | 2010-10-07 |
MX2010005629A (es) | 2010-08-18 |
AT506095A1 (de) | 2009-06-15 |
US8231870B2 (en) | 2012-07-31 |
EP2559439B1 (en) | 2014-11-26 |
WO2009070818A1 (en) | 2009-06-11 |
EP2224948A1 (en) | 2010-09-08 |
DK2559439T3 (en) | 2014-12-08 |
ES2528348T3 (es) | 2015-02-09 |
CA2705986A1 (en) | 2009-06-11 |
RU2010127336A (ru) | 2012-01-10 |
JP2011505385A (ja) | 2011-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2559439T3 (pl) | Preparat farmaceutyczny do leczenia łagodnego rozrostu gruczołu krokowego | |
IL257681A (en) | Methods and compositions for the treatment of cancer | |
IL248204A0 (en) | Combined treatment of tumors expressing 38cd | |
EP2152722A4 (en) | COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER | |
PL2578081T3 (pl) | Kompozycje, sposoby i urządzenia do leczenia chorób wątroby | |
HK1148906A1 (en) | Compositions and methods for cancer treatment | |
HK1137158A1 (en) | Formulations for cancer treatment | |
IL197389A0 (en) | Prophylactic or therapeutic agent for cancer | |
EP2049139A4 (en) | TREATMENT OF TUMORS EXPRESSING RAS | |
EP2231185A4 (en) | METHOD AND COMPOSITIONS FOR TREATING LIQUID TUMORS | |
ZA201109513B (en) | Composition for the treatment of benign prostate hyperplasia | |
EP2049151A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
EP2083840A4 (en) | IMPROVED TREATMENT FOR BENEFICIAL PROSTATE HYPERPLASIA | |
EP2018873A4 (en) | PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER | |
EP2331092A4 (en) | METHOD AND COMPOSITIONS FOR THE ADMINISTRATION OF 3-HALOPYRUVATE AND RELATED COMPOUNDS FOR THE TREATMENT OF CANCER | |
EP2004205A4 (en) | INORGANIC SELEN FOR THE TREATMENT OF GOOD TUMORS | |
IL226362A0 (en) | compounds, and methods for treating cancer | |
HK1145399A1 (en) | Pharmaceutical composition for treating hemorrhoids | |
ZA200900076B (en) | Isoindoline derivatives for the treatment of arrhythmias | |
AU2006905763A0 (en) | Improved treatment for benign prostatic hyperplasia | |
GB0710871D0 (en) | Cancer treatment | |
AU2006905835A0 (en) | Treatment of benign prostatic hyperplasia | |
AU2006900091A0 (en) | Treatment of begnign prostatic hyperplasia | |
EP2068629A4 (en) | COMPOSITIONS AND METHODS FOR TREATING CANCER | |
GB0604114D0 (en) | Combinations for the treatment of cancer |